|
Frontline Combo Dog M
|
-
|
V/NRP/24/0029
|
Boehringer Ingelheim Animal Health France SCS , Francija
|
QP53AX65
|
dogs 10-20 kg
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/24/0029-01 |
|
1 |
Pipete, 1,34 ml |
-
|
| V/NRP/24/0029-02 |
|
3 |
Pipete, 1,34 ml |
-
|
| V/NRP/24/0029-03 |
|
6 |
Pipete, 1,34 ml |
-
|
|
|
Frontline Combo Dog L
|
-
|
V/NRP/24/0030
|
Boehringer Ingelheim Animal Health France SCS , Francija
|
QP53AX65
|
dogs 20-40 kg
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/24/0030-01 |
|
1 |
Pipete, 2,68 ml |
-
|
| V/NRP/24/0030-02 |
|
3 |
Pipete, 2,68 ml |
-
|
| V/NRP/24/0030-03 |
|
6 |
Pipete, 2,68 ml |
-
|
|
|
Frontline Combo Dog XL
|
-
|
V/NRP/24/0031
|
Boehringer Ingelheim Animal Health France SCS , Francija
|
QP53AX65
|
dogs over 40 kg
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/24/0031-01 |
|
1 |
Pipete, 4,02 ml |
-
|
| V/NRP/24/0031-02 |
|
3 |
Pipete, 4,02 ml |
-
|
| V/NRP/24/0031-03 |
|
6 |
Pipete, 4,02 ml |
-
|
|
|
Intra Dysovinol
|
499 mg/ml
|
V/MRP/19/0055
|
Intracare BV, Nīderlande
|
QA07XA92
|
pigs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/19/0055-01 |
499 mg/ml |
1 |
ABPE konteiners, 5 l |
-
|
| V/MRP/19/0055-02 |
499 mg/ml |
1 |
ABPE konteiners, 10 l |
-
|
| V/MRP/19/0055-03 |
499 mg/ml |
1 |
ABPE konteiners, 20 l |
-
|
|
|
Bimoxyl LA
|
150 mg/ml
|
V/NRP/96/0318
|
Bimeda Animal Health Limited, Īrija
|
QJ01CA04
|
cattle; pigs; sheep
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/96/0318-01 |
150 mg/ml |
1 |
Stikla flakons, 100 ml |
-
|
| V/NRP/96/0318-02 |
150 mg/ml |
1 |
PET flakons, 100 ml |
-
|
| V/NRP/96/0318-03 |
150 mg/ml |
1 |
PET flakons, 250 ml |
-
|
|
|
Mcepe
|
1 mg/ml
|
V/DCP/25/0029
|
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
QA03FA01
|
dogs; cats
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/25/0029-01 |
|
1 |
Stikla flakons, 25 ml |
-
|
| V/DCP/25/0029-02 |
|
1 |
Stikla flakons, 100 ml |
-
|
|
|
Amphen
|
200 mg/ml
|
V/DCP/24/0023
|
Huvepharma NV, Beļģija
|
QJ01BA90
|
pigs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/24/0023-01 |
|
1 |
ABPE pudele, 1 l |
-
|
|
|
Enterisol Ileitis
|
-
|
V/MRP/08/1589
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QI09AE04
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate for suspension for injection
|
| International name (active substance): |
Lawsonia intracellularis
|
| Distribution category: |
To be used only by veterinary surgeon
|
| Manufacturer(s) responsible for batch release |
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
| Date of authorisation/renewal: |
30-Oct-2009
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
MRP
|
| Package leaflet: |
[DOCX] 270121LI (27-Jan-2021)
|
| Labelling text: |
[DOCX] 270121M (27-Jan-2021)
|
| Summary of product characteristics: |
[DOCX] 270121ZA (27-Jan-2021)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/08/1589-01 |
|
1 |
Stikla flakons, 10 deva |
-
|
| V/MRP/08/1589-02 |
|
1 |
Stikla flakons, 50 deva |
-
|
| V/MRP/08/1589-03 |
|
1 |
Stikla flakons, 100 deva |
-
|
| V/MRP/08/1589-04 |
|
12 |
Stikla flakons, 100 deva |
-
|
| V/MRP/08/1589-05 |
|
1 |
Polietilēna flakons, 10 deva |
-
|
| V/MRP/08/1589-06 |
|
1 |
Polietilēna flakons, 50 deva |
-
|
| V/MRP/08/1589-07 |
|
1 |
Polietilēna flakons, 100 deva |
-
|
| V/MRP/08/1589-08 |
|
12 |
Polietilēna flakons, 100 deva |
-
|
|
|
Dozuril
|
50 mg/ml
|
V/DCP/13/0038
|
Dopharma Research B.V., Nīderlande
|
QP51BC01
|
pigs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/13/0038-01 |
50 mg/ml |
1 |
PE pudele ar PE vāciņu, 250 ml |
-
|
| V/DCP/13/0038-02 |
50 mg/ml |
1 |
PE pudele ar PE vāciņu, 1000 ml |
-
|
|
|
Ingelvac PRRSFLEX EU
|
-
|
V/DCP/15/0004
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QI09AD03
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and solvent for suspension for injection
|
| International name (active substance): |
Live attenuated porcine reproductive and respiratory syndrome virus, strain 94881
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Boehringer Ingelheim Pharma GmbH & Co. KG, Vācija
|
| Date of authorisation/renewal: |
26-Feb-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[PDF] Skat_sadaļā_Zāļu_apraksts (10-Jul-2025)
|
| Labelling text: |
[PDF] Skat_sadaļā_Zāļu_apraksts (10-Jul-2025)
|
| Summary of product characteristics: |
[DOCX] Zāļu_informācija_ZA_M_LI (10-Jul-2025)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/15/0004-01 |
|
1 |
Stikla flakons, 10 deva |
-
|
| V/DCP/15/0004-02 |
|
1 |
Stikla flakons, 50 deva |
-
|
| V/DCP/15/0004-03 |
|
1 |
Stikla flakons, 100 deva |
-
|
| V/DCP/15/0004-04 |
|
1 |
Stikla flakons, 250 deva |
-
|
| V/DCP/15/0004-05 |
|
12 |
Stikla flakons, 10 deva |
-
|
| V/DCP/15/0004-06 |
|
25 |
Stikla flakons, 10 deva |
-
|
| V/DCP/15/0004-07 |
|
12 |
Stikla flakons, 50 deva |
-
|
| V/DCP/15/0004-08 |
|
25 |
Stikla flakons, 50 deva |
-
|
| V/DCP/15/0004-09 |
|
12 |
Stikla flakons, 100 deva |
-
|
| V/DCP/15/0004-10 |
|
25 |
Stikla flakons, 100 deva |
-
|
| V/DCP/15/0004-11 |
|
12 |
Stikla flakons, 250 deva |
-
|
| V/DCP/15/0004-12 |
|
25 |
Stikla flakons, 250 deva |
-
|
| V/DCP/15/0004-13 |
|
12 |
ABPE flakons (šķīdinātājs), 10 ml |
-
|
| V/DCP/15/0004-14 |
|
12 |
ABPE flakons (šķīdinātājs), 50 ml |
-
|
| V/DCP/15/0004-15 |
|
12 |
ABPE flakons (šķīdinātājs), 100 ml |
-
|
| V/DCP/15/0004-16 |
|
12 |
ABPE flakons (šķīdinātājs), 250 ml |
-
|
| V/DCP/15/0004-17 |
|
25 |
ABPE flakons (šķīdinātājs), 10 ml |
-
|
| V/DCP/15/0004-18 |
|
25 |
ABPE flakons (šķīdinātājs), 50 ml |
-
|
| V/DCP/15/0004-19 |
|
25 |
ABPE flakons (šķīdinātājs), 100 ml |
-
|
| V/DCP/15/0004-20 |
|
25 |
ABPE flakons (šķīdinātājs), 250 ml |
-
|
|
|
PESTORIN MORMYX
|
-
|
V/NRP/01/1335
|
Bioveta, a.s., Čehija
|
QI08AH01
|
rabbits
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and suspension for suspension for injection
|
| International name (active substance): |
Rabbit haemorrhagic disease virus, strain CAMP-V351, inactivated, Myxoma virus, strain CAMP V-219, Live
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Bioveta, a.s., Čehija
|
| Date of authorisation/renewal: |
27-May-2011
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[PDF] Skat_sadaļā_Zāļu_apraksts (13-May-2025)
|
| Labelling text: |
[PDF] Skat_sadaļā_Zāļu_apraksts (13-May-2025)
|
| Summary of product characteristics: |
[DOCX] Zāļu_informācija_ZA_M_LI (13-May-2025)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/01/1335-01 |
|
1 |
Stikla flakons, 1 deva |
-
|
| V/NRP/01/1335-02 |
|
5 |
Stikla flakons, 1 deva |
-
|
| V/NRP/01/1335-03 |
|
10 |
Stikla flakons, 1 deva |
-
|
| V/NRP/01/1335-04 |
|
1 |
Stikla flakons, 5 deva |
-
|
| V/NRP/01/1335-05 |
|
5 |
Stikla flakons, 5 deva |
-
|
| V/NRP/01/1335-06 |
|
10 |
Stikla flakons, 5 deva |
-
|
| V/NRP/01/1335-07 |
|
1 |
Stikla flakons, 10 deva |
-
|
| V/NRP/01/1335-08 |
|
5 |
Stikla flakons, 10 deva |
-
|
| V/NRP/01/1335-09 |
|
10 |
Stikla flakons, 10 deva |
-
|
| V/NRP/01/1335-10 |
|
1 |
Stikla flakons, 20 deva |
-
|
| V/NRP/01/1335-11 |
|
5 |
Stikla flakons, 20 deva |
-
|
| V/NRP/01/1335-12 |
|
10 |
Stikla flakons, 20 deva |
-
|
|
|
Hiprabovis Somni/Lkt
|
-
|
V/MRP/19/0029
|
Laboratorios Hipra S.A., Spānija
|
QI02AB
|
cattle
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
emulsion for injection
|
| International name (active substance): |
Mannheimia haemolytica Biotype A serotype A1, inactivated cell free suspension containing leukotoxoid, Inactivated Histophilus somni Bailie strain
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Laboratorios Hipra S.A., Spānija
|
| Date of authorisation/renewal: |
28-Jan-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
MRP
|
| Package leaflet: |
[PDF] Skat_sadaļā_Zāļu_apraksts (12-Nov-2024)
|
| Labelling text: |
[PDF] Skat_sadaļā_Zāļu_apraksts (12-Nov-2024)
|
| Summary of product characteristics: |
[DOCX] Zāļu_informācija_ZA_M_LI (12-Nov-2024)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/19/0029-01 |
|
1 |
Stikla flakons, 10 deva |
-
|
| V/MRP/19/0029-02 |
|
1 |
Stikla pudelīte, 50 deva |
-
|
|
|
Advantix 40mg/200mg
|
-
|
V/NRP/03/1599
|
Elanco Animal Health GmbH, Vācija
|
QP53AC54
|
dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/03/1599-01 |
|
1 |
Pipete, 0,4 ml |
-
|
| V/NRP/03/1599-06 |
|
2 |
Pipete, 0,4 ml |
-
|
| V/NRP/03/1599-07 |
|
3 |
Pipete, 0,4 ml |
-
|
| V/NRP/03/1599-08 |
|
4 |
Pipete, 0,4 ml |
-
|
| V/NRP/03/1599-09 |
|
6 |
Pipete, 0,4 ml |
-
|
|
|
Pestigon
|
402 mg
|
V/DCP/12/0051
|
Norbrook Laboratories (Ireland) Limited, Īrija
|
QP53AX15
|
very large dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Fipronil
|
| Distribution category: |
Nonprescription veterinary medicinal product
|
| Manufacturer(s) responsible for batch release |
Norbrook Laboratories Limited, Lielbritānija;Norbrook Laboratories Limited, Lielbritānija;Norbrook Manufacturing Limited, Īrija
|
| Date of authorisation/renewal: |
04-Jul-2017
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[PDF] Skat_sadaļā_Zāļu_apraksts (23-Mar-2026)
|
| Labelling text: |
[PDF] Skat_sadaļā_Zāļu_apraksts (23-Mar-2026)
|
| Summary of product characteristics: |
[DOCX] Zāļu_informācija_ZA_M_LI (23-Mar-2026)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/12/0051-01 |
402 mg/deva |
1 |
Plastmasas pipete, 1 deva |
-
|
| V/DCP/12/0051-02 |
402 mg/deva |
2 |
Plastmasas pipete, 1 deva |
-
|
| V/DCP/12/0051-03 |
402 mg/deva |
3 |
Plastmasas pipete, 1 deva |
-
|
| V/DCP/12/0051-04 |
402 mg/deva |
4 |
Plastmasas pipete, 1 deva |
-
|
| V/DCP/12/0051-05 |
402 mg/deva |
6 |
Plastmasas pipete, 1 deva |
-
|
| V/DCP/12/0051-06 |
402 mg/deva |
8 |
Plastmasas pipete, 1 deva |
-
|
| V/DCP/12/0051-07 |
402 mg/deva |
12 |
Plastmasas pipete, 1 deva |
-
|
| V/DCP/12/0051-08 |
402 mg/deva |
24 |
Plastmasas pipete, 1 deva |
-
|
| V/DCP/12/0051-09 |
402 mg/deva |
30 |
Plastmasas pipete, 1 deva |
-
|
| V/DCP/12/0051-10 |
402 mg/deva |
60 |
Plastmasas pipete, 1 deva |
-
|
| V/DCP/12/0051-11 |
402 mg/deva |
90 |
Plastmasas pipete, 1 deva |
-
|
| V/DCP/12/0051-12 |
402 mg/deva |
120 |
Plastmasas pipete, 1 deva |
-
|
| V/DCP/12/0051-13 |
402 mg/deva |
150 |
Plastmasas pipete, 1 deva |
-
|
|
|
Tramadol Domes Pharma
|
50 mg
|
V/DCP/22/0010
|
Axience, Francija
|
QN02AX02
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Tramadol hydrochloride
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Europhartech, Francija
|
| Date of authorisation/renewal: |
23-Feb-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[DOCX] 17072025LI (17-Jul-2025)
|
| Labelling text: |
[DOCX] 17072025M (17-Jul-2025)
|
| Summary of product characteristics: |
[DOCX] 17072025ZA (17-Jul-2025)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/22/0010-01 |
50 mg |
1 |
PVH/PVdH/Al blisteris, 10 tablete |
-
|
| V/DCP/22/0010-02 |
50 mg |
3 |
PVH/PVdH/Al blisteris, 10 tablete |
-
|
| V/DCP/22/0010-03 |
50 mg |
6 |
PVH/PVdH/Al blisteris, 10 tablete |
-
|
| V/DCP/22/0010-04 |
50 mg |
10 |
PVH/PVdH/Al blisteris, 10 tablete |
-
|
|
|
Advantix 600mg/3000mg
|
-
|
V/NRP/17/0040
|
Elanco Animal Health GmbH, Vācija
|
QP53AC54
|
dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/17/0040-01 |
|
1 |
Polipropilēna pipete, 6 ml |
-
|
| V/NRP/17/0040-02 |
|
2 |
Polipropilēna pipete, 6 ml |
-
|
| V/NRP/17/0040-03 |
|
3 |
Polipropilēna pipete, 6 ml |
-
|
| V/NRP/17/0040-04 |
|
4 |
Polipropilēna pipete, 6 ml |
-
|
| V/NRP/17/0040-05 |
|
6 |
Polipropilēna pipete, 6 ml |
-
|
|
|
Robexera
|
20 mg/ml
|
V/DCP/25/0048
|
KRKA, d.d., Novo mesto, Slovēnija
|
QM01AH91
|
dogs; cats
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/25/0048-01 |
|
1 |
Stikla flakons, 20 ml |
-
|
|
|
Vetrimoxin LA
|
150 mg/ml
|
V/NRP/03/1616
|
Ceva Sante Animale', Francija
|
QJ01CA04
|
cattle; pigs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/03/1616-01 |
150 mg/ml |
1 |
Stikla flakons, 100 ml |
-
|
| V/NRP/03/1616-02 |
150 mg/ml |
1 |
Stikla flakons, 250 ml |
-
|
| V/NRP/03/1616-03 |
150 mg/ml |
1 |
Plastikāta flakons, 250 ml |
-
|
| V/NRP/03/1616-04 |
150 mg/ml |
1 |
Plastikāta flakons, 100 ml |
-
|
| V/NRP/03/1616-05 |
150 mg/ml |
1 |
Plastikāta flakons, 50 ml |
-
|
| V/NRP/03/1616-06 |
150 mg/ml |
1 |
Plastikāta flakons, 500 ml |
-
|
|
|
Parvoruvax
|
-
|
V/NRP/02/1437
|
Ceva Sante Animale', Francija
|
QI09AL01
|
pigs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/02/1437-01 |
|
1 |
Flakons, 1 deva |
-
|
| V/NRP/02/1437-02 |
|
10 |
Flakons, 1 deva |
-
|
| V/NRP/02/1437-03 |
|
1 |
Flakons, 2 deva |
-
|
| V/NRP/02/1437-04 |
|
1 |
Flakons, 5 deva |
-
|
| V/NRP/02/1437-05 |
|
1 |
Flakons, 25 deva |
-
|
| V/NRP/02/1437-06 |
|
1 |
Flakons, 10 deva |
-
|
| V/NRP/02/1437-07 |
|
1 |
Flakons, 100 deva |
-
|
| V/NRP/02/1437-08 |
|
1 |
Stikla flakons, 50 deva |
-
|
| V/NRP/02/1437-09 |
|
1 |
ZBPE flakons, 50 deva |
-
|
|
|
Ketofen 10%
|
100 mg/ml
|
V/NRP/01/1403
|
Ceva Sante Animale', Francija
|
QM01AE03
|
cattle; pigs; horses
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/01/1403-01 |
100 mg/ml |
1 |
Stikla flakons, 50 ml |
-
|
| V/NRP/01/1403-02 |
100 mg/ml |
1 |
Stikla flakons, 100 ml |
-
|
| V/NRP/01/1403-03 |
100 mg/ml |
1 |
Plastikāta flakons, 50 ml |
-
|
| V/NRP/01/1403-04 |
100 mg/ml |
1 |
Plastikāta flakons, 100 ml |
-
|
|